Electrocardiographic alterations during interferon-free direct-acting antiviral therapy for hepatitis C virus

被引：0
|
作者：
Garcia-Arribas, D. [1 ]
Lopez-Garcia, O. N. [2 ]
Olmos, C. [1 ]
Higueras Nafria, J. [1 ]
Devesa Medina, M. J. [2 ]
Cuenca Alarcon, F. [2 ]
Izquierdo Rubio, S. [2 ]
Maroto Castellanos, M. [2 ]
Rey Diaz-Rubio, E. [2 ]
机构：
[1] Hosp Clin San Carlos, Dept Cardiol, Madrid, Spain
[2] Hosp Clin San Carlos, Dept Gastroenterol & Hepatol, Madrid, Spain
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2693
引用
收藏
页码：578 / 578
页数：1
相关论文
共 50 条
  • [41] Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
    Kiser, Jennifer J.
    Flexner, Charles
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013, 2013, 53 : 427 - 449
  • [42] Changes in lipid profile during and after hepatitis C virus (HCV) treatment with direct-acting antiviral (DAA), interferon-free regimens in patients co-infected with HIV
    Dominguez-Dominguez, Lourdes
    Bisbal, Otilia
    Lagarde, Maria
    Matarranz, Mariano
    Hernando, Asuncion
    Rubio, Rafael
    Pulido, Federico
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [43] CHARACTERISTICS AND PREVALENCE OF CHRONIC KIDNEY DISEASE AMONG PATIENTS WITH HEPATITIS C WHO ARE TREATED WITH INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS
    Puenpatom, A.
    Hull, M.
    McPheeters, J.
    Schwebke, K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S744 - S744
  • [44] Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C
    Honma, Yuichi
    Shibata, Michihiko
    Morino, Kahori
    Koya, Yudai
    Hayashi, Tsuguru
    Ogino, Noriyoshi
    Kusanaga, Masashi
    Oe, Shinji
    Miyagawa, Koichiro
    Abe, Shintaro
    Tabaru, Akinari
    Harada, Masaru
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 685 - 698
  • [45] Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations?
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 848 - 849
  • [46] Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C
    Yuichi Honma
    Michihiko Shibata
    Kahori Morino
    Yudai Koya
    Tsuguru Hayashi
    Noriyoshi Ogino
    Masashi Kusanaga
    Shinji Oe
    Koichiro Miyagawa
    Shintaro Abe
    Akinari Tabaru
    Masaru Harada
    Digestive Diseases and Sciences, 2023, 68 : 685 - 698
  • [47] Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals
    Fayed, Ahmed
    Hegazy, Mohamed Tharwat
    Biard, Lucie
    Vieira, Matheus
    El Shabony, Tarek
    Saadoun, David
    Casato, Milvia
    Visentini, Marcella
    Ragab, Gaafar
    Cacoub, Patrice
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (04): : 627 - 636
  • [48] Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy
    Toyoda, Hidenori
    Kikuchi, Kan
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (05) : 831 - 838
  • [49] Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
    Baumert, Thomas F.
    Berg, Thomas
    Lim, Joseph K.
    Nelson, David R.
    GASTROENTEROLOGY, 2019, 156 (02) : 431 - 445
  • [50] Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy
    Jadoul, Michel
    Labriola, Laura
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (01) : 158 - 159
12345